Greg Stone
Impact in
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- HIV/AIDS drug development and treatment 1
-
- Biochemical and Molecular Research 1
- Co-authors
- J. Armstrong (2 shared papers)Paul Newell (2 shared papers)Leanne B. Gasink (2 shared papers)Yehuda Carmeli (1 shared paper)Angela Wardman (1 shared paper)Peter J. Laud (1 shared paper)Lily Llorens (1 shared paper)Helen Broadhurst (1 shared paper)
- Journals
- Clinical Infectious Diseases (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)The Lancet Infectious Diseases (1 paper)American Journal of Veterinary Research (1 paper)Journal of Medicinal Chemistry (1 paper)
- Partner nations
- United StatesUnited KingdomIsrael
In The Last Decade
Greg Stone
7 papers receiving 734 citations
Greg Stone's Hit Papers
Peers
Comparison fields: 5 of 61
- Molecular Medicine 453
- Applied Microbiology and Biotechnology 147
- Pharmacology 285
- Clinical Biochemistry 57
- Epidemiology 200
Countries citing papers authored by Greg Stone
This map shows the geographic impact of Greg Stone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg Stone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg Stone more than expected).
Fields of papers citing papers by Greg Stone
This network shows the impact of papers produced by Greg Stone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg Stone. The network helps show where Greg Stone may publish in the future.
Co-authors
The 25 scholars most cited alongside Greg Stone, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 336 | |
| 2 | Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program Hit paper breakdown → | 2016 | 303 |
| 3 | 2003 | 43 | |
| 4 | 1994 | 29 | |
| 5 | 2000 | 23 | |
| 6 | 2004 | 11 | |
| 7 | 2020 | 1 | |
| 8 | 2011 | 0 |
About Greg Stone
Greg Stone is a scholar working on Infectious Diseases, Molecular Biology, Molecular Medicine, Applied Microbiology and Biotechnology and Pharmacology, having authored 8 papers that have together received 746 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (2 papers), Antibiotic Resistance in Bacteria (2 papers), Milk Quality and Mastitis in Dairy Cows (1 paper), HIV/AIDS drug development and treatment (1 paper), Child and Adolescent Health (1 paper), Veterinary Oncology Research (1 paper), Biochemical and Molecular Research (1 paper) and Bacterial Identification and Susceptibility Testing (1 paper). The work is most often cited by research in Molecular Medicine (453 citations), Applied Microbiology and Biotechnology (147 citations), Pharmacology (285 citations), Clinical Biochemistry (57 citations) and Epidemiology (200 citations). Greg Stone has collaborated with scholars based in United States, United Kingdom and Israel. Frequent co-authors include J. Armstrong, Paul Newell, Leanne B. Gasink, Yehuda Carmeli, Angela Wardman, Peter J. Laud, Lily Llorens, Helen Broadhurst, Jan Pachl and John E. Mazuski. Their work appears in journals such as Clinical Infectious Diseases, Bioorganic & Medicinal Chemistry Letters, The Lancet Infectious Diseases, American Journal of Veterinary Research and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.